180 related articles for article (PubMed ID: 22102289)
1. Global proteomics and metabolomics in cancer biomarker discovery.
Issaq HJ; Fox SD; Chan KC; Veenstra TD
J Sep Sci; 2011 Dec; 34(24):3484-92. PubMed ID: 22102289
[TBL] [Abstract][Full Text] [Related]
2. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
3. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
[TBL] [Abstract][Full Text] [Related]
4. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
5. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
Issaq HJ; Waybright TJ; Veenstra TD
Electrophoresis; 2011 Apr; 32(9):967-75. PubMed ID: 21449066
[TBL] [Abstract][Full Text] [Related]
6. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
7. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
Bakry R; Rainer M; Huck CW; Bonn GK
Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
[TBL] [Abstract][Full Text] [Related]
8. The role of electrophoresis in disease biomarker discovery.
Issaq HJ; Veenstra TD
Electrophoresis; 2007 Jun; 28(12):1980-8. PubMed ID: 17503404
[TBL] [Abstract][Full Text] [Related]
9. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
10. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human gastric fluid proteome reveals distinct pH-dependent protein profiles: implications for biomarker studies.
Kam SY; Hennessy T; Chua SC; Gan CS; Philp R; Hon KK; Lai L; Chan WH; Ong HS; Wong WK; Lim KH; Ling KL; Tan HS; Tan MM; Ho M; Kon OL
J Proteome Res; 2011 Oct; 10(10):4535-46. PubMed ID: 21842849
[TBL] [Abstract][Full Text] [Related]
12. [Application of proteomics to diagnosis and treatment of lung cancer].
Dai M; Luo RC
Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
[TBL] [Abstract][Full Text] [Related]
13. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.
Boehmer JL; DeGrasse JA; McFarland MA; Tall EA; Shefcheck KJ; Ward JL; Bannerman DD
Vet Immunol Immunopathol; 2010 Dec; 138(4):252-66. PubMed ID: 21067814
[TBL] [Abstract][Full Text] [Related]
14. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
Ahmed FE
J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
[TBL] [Abstract][Full Text] [Related]
15. Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer.
Lam YW; Mobley JA; Evans JE; Carmody JF; Ho SM
Proteomics; 2005 Jul; 5(11):2927-38. PubMed ID: 15952230
[TBL] [Abstract][Full Text] [Related]
16. [Tumor proteomics: the past, present and future].
Xu XE; Jiang YH; Shi Q
Ai Zheng; 2008 Oct; 27(10):1009-17. PubMed ID: 18851778
[TBL] [Abstract][Full Text] [Related]
17. Shotgun proteomics: tools for the analysis of complex biological systems.
Wu CC; MacCoss MJ
Curr Opin Mol Ther; 2002 Jun; 4(3):242-50. PubMed ID: 12139310
[TBL] [Abstract][Full Text] [Related]
18. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
19. An introduction into proteomics and its clinical applications.
Ahram M
Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
[TBL] [Abstract][Full Text] [Related]
20. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry.
Hu S; Yu T; Xie Y; Yang Y; Li Y; Zhou X; Tsung S; Loo RR; Loo JR; Wong DT
Cancer Genomics Proteomics; 2007; 4(2):55-64. PubMed ID: 17804867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
